Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Cholesterol Drugs May Be Good Candidates For Managed Care Pull Throughs

Executive Summary

Cholesterol-lowering agents may be good candidates for managed care pull through programs following the recent change in National Cholesterol Education Program guidelines, participants at a recent workshop on pharmaceutical managed care marketing suggested.

You may also be interested in...

Cholesterol Therapy Guidelines Stress Need To Consider Cost, Treat To Goal

The National Cholesterol Education Program treatment guidelines encourage physicians to restrict drug therapy only to high risk patients - but expand the definition of high risk to include as many as 36 mil. people in the U.S.

Harvard Pilgrim Weighing Prilosec Promotion In Face Of Less Expensive PPIs

Harvard Pilgrim Health Care is weighing the benefits of promoting AstraZeneca's Prilosec (omeprazole) within the managed care organization's network in the face of near-term patent expiration and less costly proton pump inhibitors.

Part D Discount Liability Coming Into Focus: CMS Releases Drug Cost Data

Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011



Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts